TY - JOUR AU - Pui, C. H. PY - 2010 DA - 2010// TI - Recent research advances in childhood acute lymphoblastic leukemia JO - J Formos Med Assoc VL - 109 UR - https://doi.org/10.1016/S0929-6646(10)60123-4 DO - 10.1016/S0929-6646(10)60123-4 ID - Pui2010 ER - TY - JOUR AU - Skärby, T. AU - Jönsson, P. AU - Hjorth, L. AU - Behrentz, M. AU - Björk, O. AU - Forestier, E. PY - 2003 DA - 2003// TI - High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL) JO - Cancer Chemother Pharmacol VL - 51 ID - Skärby2003 ER - TY - BOOK AU - Pizzo, P. A. AU - Poplack, D. G. PY - 2006 DA - 2006// TI - Principles and practice of pediatric oncology PB - Wilkins CY - Philadelphia ID - Pizzo2006 ER - TY - JOUR AU - Fukuhara, K. AU - Ikawa, K. AU - Morikawa, N. AU - Kumagai, K. PY - 2008 DA - 2008// TI - Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data JO - J Clin Pharm Ther VL - 33 UR - https://doi.org/10.1111/j.1365-2710.2008.00966.x DO - 10.1111/j.1365-2710.2008.00966.x ID - Fukuhara2008 ER - TY - JOUR AU - Rask, C. AU - Albertioni, F. AU - Bentzen, S. M. AU - Schroeder, H. AU - Peterson, C. PY - 1998 DA - 1998// TI - Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia—a logistic regression analysis JO - Acta Oncol VL - 37 UR - https://doi.org/10.1080/028418698429586 DO - 10.1080/028418698429586 ID - Rask1998 ER - TY - JOUR AU - Relling, M. V. AU - Fairclough, D. AU - Ayers, D. AU - Crom, W. R. AU - Rodman, J. H. AU - Pui, C. H. PY - 1994 DA - 1994// TI - Patient characteristics associated with high-risk methotrexate concentrations and toxicity JO - J Clin Oncol VL - 12 ID - Relling1994 ER - TY - JOUR AU - Perez, C. AU - Wang, Y. M. AU - Sutow, W. W. AU - Herson, J. PY - 1978 DA - 1978// TI - Significance of the 48-hour plasma level in high-dose methotrexate regimens JO - Cancer Clin Trials VL - 1 ID - Perez1978 ER - TY - JOUR AU - Stoller, R. G. AU - Hande, K. R. AU - Jacobs, S. A. AU - Rosenberg, S. A. AU - Chabner, B. A. PY - 1977 DA - 1977// TI - Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity JO - N Engl J Med VL - 297 UR - https://doi.org/10.1056/NEJM197709222971203 DO - 10.1056/NEJM197709222971203 ID - Stoller1977 ER - TY - JOUR AU - Evans, W. E. AU - Crom, W. R. AU - Abromowitch, M. AU - Dodge, R. AU - Look, A. T. AU - Bowman, W. P. PY - 1986 DA - 1986// TI - Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect JO - N Engl J Med VL - 314 UR - https://doi.org/10.1056/NEJM198602203140803 DO - 10.1056/NEJM198602203140803 ID - Evans1986 ER - TY - JOUR AU - Galpin, A. J. AU - Evans, W. E. PY - 1993 DA - 1993// TI - Therapeutic drug monitoring in cancer management JO - Clin Chem VL - 39 ID - Galpin1993 ER -